Clinical Trials in Austin

Showing 1541-1560 of 15,205 trials

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

NCT06963034

The primary objective for this study is to evaluate the efficacy of NBI-1117568 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults.

Schizophrenia

Neurocrine Biosciences284 participantsStarted May 2025

Bryant, Arkansas, United States • Little Rock, Arkansas, United States • Anaheim, California, United States +18 more locations

COMPLETEDNA< 1 mile

Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)

NCT05845710

The PERFORMANCE III study is a prospective, multicenter single-arm, open label study to evaluate the safety and effectiveness of the Neuroguard IEP® Direct System for the treatment of carotid artery stenosis in subjects at elevated risk for carotid endarterectomy (CEA). Eligible patients greater than or equal to 20 years of age and less than or equal to 82 years of age, are those who have been diagnosed with either de-novo atherosclerotic or post CEA restenotic lesion(s) in the internal carotid arteries (ICA) or at the carotid bifurcation with greater than or equal to 50% stenosis if symptomatic or greater than or equal to 70% stenosis if asymptomatic.

Carotid StenosisCarotid Artery Diseases

Contego Medical, Inc.178 participantsStarted Oct 2023

Scottsdale, Arizona, United States • Hartford, Connecticut, United States • Washington D.C., District of Columbia, United States +29 more locations

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)

Find Trials by Condition in Austin

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant

Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002)

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers

A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder

A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors

Lu AF28996 in Participants With Parkinson's Disease (PD)

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis